en
Feedback
๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ

๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ

Open in Telegram

ุจุณู… ุงู„ู„ู‡ ุงู„ุฑุญู…ู† ุงู„ุฑุญูŠู… ุงู„ู„ู‡ู… ุตู„ ุนู„ู‰ ู…ุญู…ุฏ ูˆุขู„ ู…ุญู…ุฏ ู…ุญุชูˆู‰ ุงู„ู‚ู†ุงุฉ: ุดุฑูˆุญุงุช ุตูŠุฏู„ุฉ ุนุถูˆูŠุฉ ู…ุฑุญู„ุฉ ุซุงู†ูŠุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุซุงู„ุซุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุฑุงุจุนุฉ ูƒูˆุฑุณ ุงูˆู„ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุฑุงุจุนุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ุนู„ุงุฌูŠุงุช ู…ุฑุญู„ุฉ ุฎุงู…ุณุฉ ู„ู„ุชูˆุงุตู„: @AronX2bot

Show more

๐Ÿ“ˆ Analytical overview of Telegram channel ๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ

Channel ๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ (@aronstudy) in the Arabic language segment is an active participant. Currently, the community unites 13 329 subscribers, ranking 1 928 in the Medicine category and 5 694 in the Saudi Arabia region.

๐Ÿ“Š Audience metrics and dynamics

Since its creation on ะฝะตะฒั–ะดะพะผะพ, the project has demonstrated rapid growth, gathering an audience of 13 329 subscribers.

According to the latest data from 29 June, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by 168 over the last 30 days and by -26 over the last 24 hours, overall reach remains high.

  • Verification status: Not verified
  • Engagement rate (ER): The average audience engagement rate is 28.47%. Within the first 24 hours after publication, content typically collects 9.84% reactions from the total number of subscribers.
  • Post reach: On average, each post receives 3 795 views. Within the first day, a publication typically gains 1 312 views.
  • Reactions and interaction: The audience actively supports content: the average number of reactions per post is 37.
  • Thematic interests: Content is focused on key topics such as ู…ูŽุงุฏูŽู‘ุฉ, ุทูŽุงู„ูุจ, ุงูุณุชูุจููŠูŽุงู†, ุณูŽู„ูŽุงู…, ุฑูุณูŽุงู„ูŽุฉ.

๐Ÿ“ Description and content policy

The author describes the resource as a platform for expressing subjective opinions:
โ€œุจุณู… ุงู„ู„ู‡ ุงู„ุฑุญู…ู† ุงู„ุฑุญูŠู… ุงู„ู„ู‡ู… ุตู„ ุนู„ู‰ ู…ุญู…ุฏ ูˆุขู„ ู…ุญู…ุฏ ู…ุญุชูˆู‰ ุงู„ู‚ู†ุงุฉ: ุดุฑูˆุญุงุช ุตูŠุฏู„ุฉ ุนุถูˆูŠุฉ ู…ุฑุญู„ุฉ ุซุงู†ูŠุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุซุงู„ุซุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุฑุงุจุนุฉ ูƒูˆุฑุณ ุงูˆู„ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุฑุงุจุนุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ุนู„ุงุฌูŠุงุช ู…ุฑุญู„ุฉ ุฎุงู…ุณุฉ ู„ู„ุชูˆุงุตู„: @AronX2botโ€

Thanks to the high frequency of updates (latest data received on 30 June, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.

13 329
Subscribers
-2624 hours
+2647 days
+16830 days
Posts Archive
ุนุฏู„ุช ุนู„ู‰ ุงู„ู…ู„ู ูู‚ุท ุณู„ุงูŠุฏ 17 ุตุงุฑ ุจูŠู‡ ุชุนุฏูŠู„ ุงุฐุง ุงุญุฏ ุณุญุจ ุงู„ู…ู„ู ู ุจุณ ุณู„ุงูŠุฏ ูกูง ุฎู„ ูŠุณุญุจู‡

ุดุจุงุจ ู‡ุฐุง ุดุฑุญ ู„ู„ู…ุฑุญู„ุฉ ุงู„ุฎุงู…ุณุฉ ุงู„ุฑุงุจุนุฉ ุงู„ุนุงู… ุดุงุฑุญ ุงู„ู…ูˆุถูˆุน ู„ุง ุชุฏูˆุฎูˆู†

ุงู„ุณู„ุงู… ุนู„ูŠูƒู… ุงุญู†ุง ุทู„ุงุจ ุตูŠุฏู„ุฉ ู…ุฑุญู„ุฉ ุฎุงู…ุณุฉ ุนุฏู†ู‡ ุจุญุซ ุชุฎุฑุฌ ุนู† ุงู„ู€Skin Care ูˆ ู†ุญุชุงุฌ ู…ุดุงุฑูƒุฉ ุฒู…ู„ุงุฆู†ุง ุงู„ุตูŠุงุฏู„ุฉ ุจุงู„ุงุณุชุจูŠุงู† ุญุชู‰ ู†ูƒู…ู„ ุฌู…ุน ุงู„ุจูŠุงู†ุงุช https://forms.gle/Mxq4vBT1TERcXggG8

https://docs.google.com/forms/d/e/1FAIpQLScsqY5I3nuOTLxT0CeJwcu7y7MwE3DRIqRvYXAZw_QnsTTaSg/viewform?usp=header ุงู„ุณู„ุงู… ุนู„ูŠูƒู…ุŒ ูŠุฑุฌู‰ ุงู„ุชูุถู„ ุจุงู„ู…ุดุงุฑูƒุฉ ููŠ ู‡ุฐุง ุงู„ุงุณุชุจูŠุงู† ุงู„ุนู„ู…ูŠ ุงู„ุฐูŠ ูŠู‡ุฏู ุฅู„ู‰ ู‚ูŠุงุณ ู…ุณุชูˆู‰ ุงู„ูˆุนูŠ ุญูˆู„ ููˆุงุฆุฏ ุฃูˆู…ูŠุบุง-3 ููŠ ุชู‚ู„ูŠู„ ุงู„ุงู„ุชู‡ุงุจุงุช ูˆุชุญุณูŠู† ุฏู‡ูˆู† ุงู„ุฏู…. ู„ู† ูŠุณุชุบุฑู‚ ู…ู† ูˆู‚ุชูƒ ุฃูƒุซุฑ ู…ู† ุฏู‚ูŠู‚ุชูŠู†. ุดูƒุฑุงู‹ ู„ู…ุณุงู‡ู…ุชูƒ!"

ุงู„ุณู„ุงู… ุนู„ูŠูƒู… ุจู„ุง ุฒุญู…ุฉ ุฅุฐุง ุชฺฏุฏุฑูˆู† ุชู…ู„ูˆู† ู‡ุงูŠ ุงู„ููˆุฑู…ุง ู„ุฅูƒู…ุงู„ ู…ุชุทู„ุจุงุช ุงู„ุชุฎุฑุฌ ูˆู†ูƒูˆู† ุดุงูƒุฑูŠู† ุฃู„ูƒู…. https://docs.google.com/forms/d/e/1FAIpQLSfUfNNexJ6A6dpd_mQm1dX65Mf6kAWx0_PS1v1UsarVWWq8cw/viewform?usp=header

https://docs.google.com/forms/d/e/1FAIpQLSe7YQk0FAs2jefecE0sJ7n3IyVTPhLEaY4-x7HRYReCjn1anw/viewform?usp=header ุงู„ุณู„ุงู… ุนู„ูŠูƒู… ูˆุฑุญู…ุฉ ุงู„ู„ู‡ ุงุญู†ู‡ ู…ุฌู…ูˆุนุฉ ุทู„ุงุจ ุตูŠุฏู„ุฉ ู…ุฑุญู„ุฉ ุฎุงู…ุณุฉ.... "ุนุฏู†ู‡ ู‡ุฐุง ุงู„ุงุณุชุจูŠุงู† ู„ู…ุนุฑูุฉ ุนุฏุฏ ุงู„ุตูŠุงุฏู„ุฉ ุงู„ูŠ ูŠูˆุตููˆู† ุงู„ุทุฑูŠู‚ุฉ ุงู„ุตุญูŠุญุฉ ู„ุงุณุชุฎุฏุงู… ุงุฌู‡ุฒุฉ ุงู„ุงุณุชู†ุดุงู‚ ู„ู…ุฑุถู‰ ุงู„ุฑุจูˆ ูˆุญุงุจูŠู† ุชุดุงุฑูƒูˆู†ู‡ ุจุฌุฒุก ู…ู† ุฑุญู„ุชู†ู‡ ุจุจุญุซ ุงู„ุชุฎุฑุฌ ๐Ÿค

ุทู„ุงุจ ุงู„ุฑุงุจุนุฉ ุงู„ูุงุฑู…ุง ู…ุซุจุช ุซุงู†ูŠ ุฑุณุงู„ุฉ ูˆุฑู‡ ุนู„ุงุฌูŠุงุช ุงู„ุฎุงู…ุณุฉ๐Ÿ™

Thyroid gland disorders Copy 3.pdf6.07 MB

Adrenal Gland Disorders Copy.pdf8.37 MB

Applied Therapeutic ฤฑฤฑ โ—โ—‹โ—‹โ—โ—‹โ—‹โ—โ—‹โ—‹โ— ุจุงู„ุงุนุชู…ุงุฏ ุนู„ู‰ ุงู„ู…ู†ู‡ุฌ ุงู„ู…ูˆุญุฏ ูขู ูขูฆ 1. Adrenal Gland Disorders โ—PDF โ—Explain 2. Thyroid Gland Disorders โ—PDF โ—Explain 3. Alzheimer Disease โ—PDF โ—Explain 4. Anxiety Disorders โ—PDF โ—Explain 5. Depressive Disorders โ—PDF โ—Explain 6. Schizophrenia โ—PDF โ—Explain 7. Insomnia โ—PDF โ—Explain 8. Contraception โ—PDF โ—Explain 9. Hormone Replacement Therapy โ—PDF โ—Explain 10. Menstruation Related Disorders โ—PDF โ—Explain 11. Cancer Chemotherapy & Treatment โ—PDF โ—Explain 12. Leukemias โ—PDF โ—Explain 13. Lymphomas โ—PDF โ—Explain 14. Breast Cancer โ—PDF โ—Explain 15. Prostate Cancer โ—PDF โ—Explain 16. Adverse Effects Of Chemotherapy โ—PDF โ—Explain ๐“„ผ๐“„น๐“„ผ๐“„น๐“„ผ๐“„น๐“„ผ๐“„น๐“„ผ๐“„น๐“„ผ๐“„น๐“„ผ๐“„น๐“„ผ๐“„น๐“„ผ๐“„น๐“„ผ๐“„น๐“„ผ๐“„น๐“„ผ๐“„น๐“„ผ๐“„น๐“„ผ๐“„น๐“„ผ๐“„น๐“„ผ๐“„น๐“„ผ ๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ